Crumly & Associates Inc. Purchases 184 Shares of MetLife, Inc. (NYSE:MET)

Crumly & Associates Inc. grew its position in MetLife, Inc. (NYSE:MET) by 3.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,326 shares of the financial services provider’s stock after acquiring an additional 184 shares during the quarter. Crumly & Associates Inc.’s holdings in MetLife were worth $518,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also modified their holdings of the company. MeadowBrook Investment Advisors LLC increased its position in MetLife by 244.4% in the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. grew its stake in shares of MetLife by 131.9% in the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after buying an additional 186 shares in the last quarter. Peterson Financial Group Inc. bought a new stake in shares of MetLife in the 3rd quarter worth about $30,000. Retirement Wealth Solutions LLC purchased a new stake in shares of MetLife during the 4th quarter valued at about $32,000. Finally, Sierra Ocean LLC bought a new position in shares of MetLife in the 4th quarter valued at about $32,000. 94.99% of the stock is owned by hedge funds and other institutional investors.

MetLife Price Performance

MetLife stock opened at $82.82 on Friday. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16. The stock has a market cap of $57.34 billion, a price-to-earnings ratio of 13.87, a price-to-earnings-growth ratio of 0.66 and a beta of 1.07. The firm has a 50-day moving average of $83.45 and a two-hundred day moving average of $81.26. MetLife, Inc. has a 1 year low of $67.30 and a 1 year high of $89.05.

MetLife (NYSE:MET) last issued its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. On average, research analysts forecast that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be issued a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, February 4th. This represents a $2.18 annualized dividend and a dividend yield of 2.63%. MetLife’s dividend payout ratio is presently 36.52%.

Analyst Ratings Changes

Several equities research analysts have weighed in on MET shares. Wells Fargo & Company boosted their price objective on MetLife from $92.00 to $97.00 and gave the stock an “overweight” rating in a research note on Wednesday. JPMorgan Chase & Co. boosted their target price on MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. TD Cowen raised their price target on MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a research report on Wednesday, November 27th. Keefe, Bruyette & Woods cut their price objective on shares of MetLife from $100.00 to $98.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 12th. Finally, Barclays lowered their target price on shares of MetLife from $96.00 to $95.00 and set an “overweight” rating for the company in a report on Friday, February 7th. Two investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $92.58.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.